Early research (Phase 1)Ended earlyNCT04272203
What this trial is testing
Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers
Who this might be right for
Acute Myeloid Leukemia (AML)Non Small Cell Lung CancerCancer
AbbVie 14